OA10202A - Positive inotropic and lusitropic pyrroloquinolinone derivatives - Google Patents

Positive inotropic and lusitropic pyrroloquinolinone derivatives Download PDF

Info

Publication number
OA10202A
OA10202A OA60756A OA60756A OA10202A OA 10202 A OA10202 A OA 10202A OA 60756 A OA60756 A OA 60756A OA 60756 A OA60756 A OA 60756A OA 10202 A OA10202 A OA 10202A
Authority
OA
OAPI
Prior art keywords
formula
compound
compounds
pct
optionally substituted
Prior art date
Application number
OA60756A
Other languages
English (en)
Inventor
Eddy Jean Edgard Freyne
Alfons Herman Margaretha Raeymaekers
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of OA10202A publication Critical patent/OA10202A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Cardiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Hospice & Palliative Care (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Neurology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pyrrole Compounds (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
OA60756A 1993-06-21 1995-12-21 Positive inotropic and lusitropic pyrroloquinolinone derivatives OA10202A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP93201771 1993-06-21

Publications (1)

Publication Number Publication Date
OA10202A true OA10202A (en) 1996-12-18

Family

ID=8213908

Family Applications (1)

Application Number Title Priority Date Filing Date
OA60756A OA10202A (en) 1993-06-21 1995-12-21 Positive inotropic and lusitropic pyrroloquinolinone derivatives

Country Status (29)

Country Link
US (1) US5602134A (lv)
EP (1) EP0707586B1 (lv)
JP (1) JP2812804B2 (lv)
KR (1) KR0181560B1 (lv)
CN (1) CN1043765C (lv)
AT (1) ATE171179T1 (lv)
AU (1) AU679077B2 (lv)
BG (1) BG62171B1 (lv)
BR (1) BR9406899A (lv)
CA (1) CA2163122C (lv)
CZ (1) CZ284350B6 (lv)
DE (1) DE69413398T2 (lv)
FI (1) FI109124B (lv)
HU (1) HU220670B1 (lv)
IL (1) IL110055A (lv)
LT (1) LT3447B (lv)
LV (1) LV11545B (lv)
MY (1) MY110751A (lv)
NO (1) NO305366B1 (lv)
OA (1) OA10202A (lv)
PH (1) PH31308A (lv)
PL (1) PL176783B1 (lv)
RU (1) RU2129554C1 (lv)
SG (1) SG49717A1 (lv)
SI (1) SI9420041A (lv)
SK (1) SK280400B6 (lv)
TW (1) TW593317B (lv)
WO (1) WO1995000512A1 (lv)
ZA (1) ZA944382B (lv)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7208497B2 (en) 2001-07-02 2007-04-24 Novo Nordisk A/S Substituted piperazines and diazepanes
US20030186963A1 (en) 2001-09-14 2003-10-02 Dorwald Florencio Zaragoza Substituted piperidines
JP2005508907A (ja) * 2001-09-14 2005-04-07 ノボ　ノルディスク　アクティーゼルスカブ ヒスタミンｈ３受容体に選択的に結合する置換されたピペリジン
TWI498115B (zh) * 2007-12-27 2015-09-01 Daiichi Sankyo Co Ltd 咪唑羰基化合物
GB0808944D0 (en) * 2008-05-16 2008-06-25 Shire Llc Substituted quinazolines
GB0808953D0 (en) * 2008-05-16 2008-06-25 Shire Llc substituted quinazolines
RU2457208C2 (ru) * 2009-07-06 2012-07-27 Государственное образовательное учреждение высшего профессионального образования "Пермская государственная фармацевтическая академия Федерального агентства по здравоохранению и социальному развитию" (ГОУ ВПО "ПГФА Росздрава") 1H-ПИРРОЛО[3,4-b]ХИНОЛИН-3,9(2H,4H)-ДИОНЫ, ОБЛАДАЮЩИЕ ПРОТИВОТУБЕРКУЛЕЗНОЙ АКТИВНОСТЬЮ, И СПОСОБ ИХ ПОЛУЧЕНИЯ
WO2024149378A1 (zh) * 2023-01-13 2024-07-18 上海超阳药业有限公司 喹啉酮化合物和萘啶酮化合物及其用途

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4775674A (en) 1986-05-23 1988-10-04 Bristol-Myers Company Imidazoquinolinylether derivatives useful as phosphodiesterase and blood aggregation inhibitors
CN1030196C (zh) * 1989-07-07 1995-11-01 詹森药业有限公司 增强收缩力和舒张力的-二氢咪唑并喹唑啉酮衍生物的制备方法
NZ234186A (en) * 1989-07-07 1991-10-25 Janssen Pharmaceutica Nv Imidazo quinazolin-one derivatives and pharmaceutical compositions
US5220023A (en) * 1989-07-18 1993-06-15 Janssen Pharmaceutica N.V. Glycine derivatives
US4943573A (en) * 1989-11-01 1990-07-24 Bristol-Myers Squibb Company Imidazo[4,5-b]quinolinyloxyalkanoic acid amides with enhanced water solubility
US5196428A (en) * 1992-04-03 1993-03-23 Bristol-Myers Squibb Company Imidazo[4,5-b]qinolinyl oxy alkyl ureas

Also Published As

Publication number Publication date
BR9406899A (pt) 1996-04-09
LT3447B (en) 1995-10-25
TW593317B (en) 2004-06-21
PL312252A1 (en) 1996-04-01
LV11545B (en) 1997-08-20
BG100209A (bg) 1996-07-31
BG62171B1 (bg) 1999-04-30
ATE171179T1 (de) 1998-10-15
FI109124B (fi) 2002-05-31
PH31308A (en) 1998-07-06
CZ336695A3 (en) 1996-03-13
CZ284350B6 (cs) 1998-10-14
NO955028L (no) 1995-12-12
SG49717A1 (en) 1998-06-15
PL176783B1 (pl) 1999-07-30
DE69413398T2 (de) 1999-04-15
NO955028D0 (no) 1995-12-12
EP0707586B1 (en) 1998-09-16
JP2812804B2 (ja) 1998-10-22
WO1995000512A1 (en) 1995-01-05
IL110055A (en) 1997-09-30
SK280400B6 (sk) 2000-01-18
SI9420041A (en) 1996-08-31
ZA944382B (en) 1995-12-20
IL110055A0 (en) 1994-10-07
DE69413398D1 (de) 1998-10-22
MY110751A (en) 1999-02-27
CA2163122A1 (en) 1995-01-05
SK159695A3 (en) 1997-01-08
EP0707586A1 (en) 1996-04-24
CN1125945A (zh) 1996-07-03
HU220670B1 (hu) 2002-04-29
KR0181560B1 (ko) 1999-05-01
CA2163122C (en) 2005-06-14
FI956143A (fi) 1995-12-20
HU9501970D0 (en) 1995-09-28
LTIP1960A (en) 1995-01-31
US5602134A (en) 1997-02-11
FI956143A0 (fi) 1995-12-20
AU7000894A (en) 1995-01-17
JPH09500108A (ja) 1997-01-07
RU2129554C1 (ru) 1999-04-27
LV11545A (lv) 1996-10-20
HUT72090A (en) 1996-03-28
NO305366B1 (no) 1999-05-18
AU679077B2 (en) 1997-06-19
CN1043765C (zh) 1999-06-23

Similar Documents

Publication Publication Date Title
EP0406958B1 (en) Positive inotropic and lusitropic 3,5-dihydroimidazo[2,1-b]quinazolin-2(1H)-one derivatives
KR100787649B1 (ko) 1-[(벤조이미다졸-1-일)퀴놀린-8-일]피페리딘-4-일아민유도체의 제조 방법
NO338263B1 (no) Imidazolforbindelser, farmasøytiske sammensetninger inneholdende slike, og anvendelse derav for behandling av en sykdom eller tilstand assosiert med modulering av Notch signaliseringsreaksjonsveien
JPWO2004037812A1 (ja) 複素環式化合物及びそれを有効成分とする抗腫瘍剤
WO2007026962A1 (ja) フェニレン誘導体
SG192446A1 (en) Process for the preparation of benzoimidazol-2-yl pyrimidine derivatives
JP3269574B2 (ja) メタノアントラセン化合物、これを含有する神経精神障害を治療するための調剤学的組成物、およびこの化合物を製造するための方法および中間体
OA10202A (en) Positive inotropic and lusitropic pyrroloquinolinone derivatives
AU2016288534A1 (en) Bicyclic heterocycle derivatives as bromodomain inhibitors
CN112047962B (zh) 2H-噻唑并[3,2-b]-1,2,4-三嗪-3,7-二酮类衍生物及应用
US5919806A (en) Medicines for cardiac insufficiency
CN116283920B (zh) 2,4-二取代吡啶类化合物及其应用
NZ267647A (en) Pyrroloquinolinone derivatives, medicaments thereof and pyrrole intermediates
JPS63104964A (ja) 強心剤４−エチル−１，３−ジヒドロ−５−〔４−（２−メチル−１ｈ−イミダゾール−１−イル）ベンゾイル〕−２ｈ−イミダゾール−２−オンのプロドラッグ誘導体
MXPA94004666A (en) Inotropic and positive lusitropic derivatives of pirroloquinolin
EP4422753A1 (en) Imidazolone derivatives as inhibitors of protein kinases in particular dyrk1a, clk1 and/or clk4
JP2000128866A (ja) ２−アシルキノリン誘導体
IL120508A (en) History of acid 3-] 2,5-dioxo-3-pyrolinidine (methyl [4-nitro) or amino (phenoxyalkanoic) and alkylcarbamic (
JPH069564A (ja) テトラヒドロキノリン誘導体
JP2006512322A (ja) イミダゾリル化合物の製造のための新規な方法